In T2D patients with hyperinsulinemia, metformin improves glycemic control by enhancing insulin sensitivity in muscle increasing glucose uptake and in liver, decreasing the production of hepatic glucose [39]. This evidence concerns the gene INS and Hyperinsulinemia.